GO:0000019 regulation of mitotic recombination: Mechanisms, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0000019 regulation of mitotic recombination describes any process that modulates the frequency, rate or extent of DNA recombination during mitosis.
• Mitotic recombination is tightly controlled across the cell cycle, with homologous recombination (HR) largely restricted to S and G2 phases when sister chromatids are available.
• Key regulators include Rad51, Rad54, Hed1, Polθ, and the PLK1 kinase, which coordinate recombination with cell cycle progression.
• Dysregulation of mitotic recombination contributes to genome instability, centromere rearrangements, and cancer.
• Studying this process requires integrated approaches such as knockout, point-mutation, and knock-in cell models combined with CRISPR screening and bioinformatics.
• EDITGENE provides end-to-end CRISPR services to dissect the regulation of mitotic recombination in disease-relevant models.
Description
Regulation of mitotic recombination (GO:0000019) is a fundamental biological process that controls the frequency, rate, and extent of DNA recombination during mitosis. Mitotic recombination is essential for repairing DNA double-strand breaks (DSBs) that arise during DNA replication or from exogenous damage, and it also influences genome stability by managing recombination between repetitive sequences. The process is exquisitely regulated to ensure that recombination occurs at the right time and place, primarily during S and G2 phases when sister chromatids are available as repair templates. Dysregulation of mitotic recombination can lead to loss of heterozygosity, chromosomal rearrangements, and aneuploidy, which are hallmarks of cancer and other genomic disorders. Understanding how mitotic recombination is regulated is therefore critical for basic biology and for developing therapeutic strategies that target recombination defects in disease. This article integrates authoritative QuickGO annotation and verified PubMed literature to provide a research-grade overview of GO:0000019, covering its definition, mechanisms, key genes, disease links, and experimental models for study.
regulation of mitotic recombination At A Glance
| GO ID | GO:0000019 |
|---|---|
| GO term | regulation of mitotic recombination |
| Ontology | biological_process |
| Synonym | regulation of recombination within rDNA repeats |
| Definition | Any process that modulates the frequency, rate or extent of DNA recombination during mitosis. |
| Major function | Controls the timing, frequency, and extent of homologous recombination during mitosis to maintain genome stability. |
| Key regulators | Rad51, Rad54, Hed1, Polθ, PLK1, and cell cycle kinases. |
| Associated diseases | Cancer, genomic instability disorders, and diseases linked to defective DNA repair. |
| Research methods | CRISPR knockout/knock-in, live-cell imaging, recombination reporters, and bioinformatics. |
What Is GO:0000019?
According to the Gene Ontology, GO:0000019 (regulation of mitotic recombination) is defined as any process that modulates the frequency, rate or extent of DNA recombination during mitosis. This includes the regulation of recombination within ribosomal DNA (rDNA) repeats, as captured by the synonym 'regulation of recombination within rDNA repeats'. In essence, it encompasses all molecular events that ensure mitotic recombination is executed accurately and only when needed, preventing inappropriate or excessive recombination that could destabilize the genome.
Why Is regulation of mitotic recombination Important in Cell Biology?
Regulation of mitotic recombination is crucial because it safeguards the genome during cell division. Uncontrolled or mis-timed recombination can cause chromosomal rearrangements, loss of heterozygosity, and cell death, while insufficient recombination leads to persistent DNA damage and mutations. Many chemotherapeutic agents and radiation therapies rely on inducing DNA damage; understanding how mitotic recombination is regulated can reveal resistance mechanisms and new targets for cancer therapy. Moreover, this process is fundamental to the maintenance of repetitive DNA regions, such as centromeres and rDNA, where aberrant recombination can trigger genome instability.
• Maintains genome stability by repairing DNA double-strand breaks during mitosis.
• Prevents deleterious recombination between repetitive sequences, including centromeric and rDNA repeats.
• Coordinates recombination with the cell cycle to ensure sister chromatid availability.
• Dysregulation leads to loss of heterozygosity and chromosomal rearrangements, driving cancer.
• Influences sensitivity to DNA-damaging agents used in chemotherapy and radiotherapy.
• Plays a role in aging and age-related genomic instability.
• Provides a target for synthetic lethal strategies in cancers with homologous recombination defects.
• Essential for understanding meiotic versus mitotic recombination differences.
• Impacts gene editing outcomes by influencing homology-directed repair efficiency.
• Relevant to biotechnological applications requiring precise genome engineering.
What Happens During regulation of mitotic recombination?
Cell cycle-dependent initiation of recombination
In simple terms: Recombination is turned on mainly when cells are copying their DNA or preparing to divide.
Mitotic recombination is initiated by DNA double-strand breaks (DSBs) that occur during DNA replication or after DNA damage. The cell cycle regulates the availability of key recombination proteins; for example, cyclin-dependent kinases (CDKs) phosphorylate and activate resection factors, ensuring that homologous recombination (HR) is restricted to S and G2 phases when sister chromatids are present. This temporal control prevents recombination in G1, where it could lead to loss of heterozygosity.
Resection and Rad51 filament formation
In simple terms: The broken DNA ends are chewed back to create single-stranded tails that search for a matching template.
DSB ends are resected to generate 3' single-stranded DNA (ssDNA) overhangs, which are bound by replication protein A (RPA). Rad51 then replaces RPA to form a nucleoprotein filament that invades a homologous duplex, typically the sister chromatid. This step is regulated by accessory factors such as Rad54, which stabilizes the Rad51 filament and promotes strand invasion. In mitotic cells, Hed1 inhibits Rad51 activity to prevent inappropriate recombination, a mechanism that is relieved during meiosis.
Resolution of recombination intermediates
In simple terms: The cross-shaped DNA structures formed during recombination are cut and rejoined to finish the repair.
Recombination intermediates, including Holliday junctions and displacement loops (D-loops), must be resolved to complete repair. This involves structure-selective nucleases and helicases that process these intermediates into either crossover or non-crossover products. In mitotic cells, resolution is biased toward non-crossovers to maintain genome stability, and this bias is regulated by cell cycle kinases and accessory proteins.
Alternative repair by polymerase theta (Polθ)
In simple terms: When the main recombination pathway is unavailable, a backup enzyme called Polθ fixes breaks, especially in mitosis.
Polθ (encoded by POLQ) mediates microhomology-mediated end joining (MMEJ), an alternative DSB repair pathway that operates during mitosis. Polθ is phosphorylated by PLK1, which promotes its recruitment to DSBs and its repair activity specifically in mitosis. This regulation ensures that backup repair is available when homologous recombination is compromised, but also contributes to mutagenic repair and therapy resistance.
Regulation of recombination between repetitive sequences
In simple terms: The cell carefully controls recombination between similar DNA repeats to avoid rearrangements.
Recombination between repetitive DNA elements, such as centromeric repeats and rDNA, is tightly regulated to prevent chromosomal rearrangements. For instance, factors that suppress recombination within centromeres help maintain centromere identity and chromosome segregation fidelity. Dysregulation of this control can lead to centromere rearrangements and aneuploidy, which are common in cancer.
Key Genes Involved in GO:0000019 regulation of mitotic recombination
The following genes and proteins are central to the regulation of mitotic recombination, as supported by the verified literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| RAD51 | Forms nucleoprotein filament for strand invasion | Key recombinase; target for cancer therapy |
| RAD54 | Stabilizes Rad51 filament and promotes strand invasion | Regulates recombination efficiency |
| HED1 | Inhibits Rad51 during mitosis to prevent inappropriate recombination | Mitotic-specific regulator |
| POLQ | Mediates MMEJ repair; phosphorylated by PLK1 in mitosis | Alternative repair pathway; drug target |
| PLK1 | Phosphorylates Polθ to promote mitotic DSB repair | Cell cycle kinase; cancer target |
| MRE11 | Part of MRN complex; initiates end resection | DSB sensing and resection |
| RAD50 | Part of MRN complex; holds DNA ends | DSB repair complex |
| NBS1 | Part of MRN complex; recruits ATM | DNA damage signaling |
| EXO1 | Long-range resection nuclease | Generates ssDNA for Rad51 loading |
| SGS1 | Helicase that dissolves recombination intermediates | Prevents crossovers |
| MUS81 | Structure-selective nuclease | Resolves recombination intermediates |
| SLX1 | Structure-selective nuclease | Resolves Holliday junctions |
| SLX4 | Scaffold for nucleases | Coordinates resolution |
| RAD52 | Mediates single-strand annealing | Backup recombination pathway |
| RAD59 | Rad52 paralog; promotes recombination | Fine-tunes recombination |
| RPA | Binds ssDNA and removes secondary structure | Essential for Rad51 loading |
| CDC5 | Cell cycle kinase (CDK) that regulates resection | Links cell cycle to recombination |
How Is regulation of mitotic recombination Regulated?
Regulation of mitotic recombination is governed by cell cycle-dependent phosphorylation events. Cyclin-dependent kinases (CDKs) phosphorylate resection factors and Rad51 accessory proteins to restrict recombination to S/G2 phases. In mitosis, PLK1 phosphorylates Polθ to promote MMEJ, providing a backup repair mechanism when HR is unavailable. Additionally, the Rad51 inhibitor Hed1 is expressed in mitotic cells to prevent inappropriate recombination, and its degradation is required for meiotic recombination. These layers of regulation ensure that recombination occurs with the correct timing and fidelity.
regulation of mitotic recombination and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| POLQ | Cancer, therapy resistance | Knockout and point-mutation cell lines |
| RAD51 | Cancer, Fanconi anemia-like phenotypes | Knock-in of patient mutations |
| PLK1 | Cancer, mitotic defects | Overexpression and knockout models |
| HED1 | Genome instability (yeast model) | Knockout yeast strains |
| RAD54 | Cancer predisposition | Knockout mouse models |
Cancer and genome instability
Dysregulation of mitotic recombination leads to genome instability, a hallmark of cancer. Loss of HR factors such as BRCA1/2 causes reliance on error-prone pathways like MMEJ, mediated by Polθ, which can drive mutagenesis and therapy resistance. Overexpression of Polθ is observed in many cancers and correlates with poor prognosis, making it a promising therapeutic target. Additionally, aberrant recombination between centromeric repeats can cause aneuploidy, further promoting tumorigenesis.
Chemotherapy and radiotherapy resistance
Tumors with defective HR often become resistant to DNA-damaging agents by upregulating alternative repair pathways. PLK1-mediated phosphorylation of Polθ enhances MMEJ in mitosis, contributing to resistance to PARP inhibitors and radiation. Targeting this regulation could sensitize resistant tumors to therapy.
Developmental disorders and aging
Defects in mitotic recombination regulation can cause developmental abnormalities and premature aging due to accumulated DNA damage. While specific diseases are not fully defined, mouse models with mutations in recombination regulators exhibit growth defects and genomic instability. Further research is needed to link specific regulatory steps to human syndromes.
From regulation of mitotic recombination-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does gene X regulate mitotic recombination frequency? | CRISPR knockout in HeLa or U2OS cells |
| Does a specific point mutation in RAD51 affect filament stability? | Point-mutation knock-in via CRISPR |
| How does PLK1 phosphorylation of Polθ affect mitotic repair? | Phospho-mutant knock-in |
| Can overexpression of Polθ drive therapy resistance? | Doxycycline-inducible overexpression |
| What is the role of Hed1 in preventing mitotic recombination? | Yeast knockout and tagged knock-in |
| How do centromeric repeats recombine? | CRISPR-engineered reporter at centromere |
How to Study the regulation of mitotic recombination Process
| Method | What It Measures | Typical Application |
|---|---|---|
| Direct repeat recombination assay | Frequency of homologous recombination | Screening for regulators |
| Live-cell imaging | Recruitment kinetics of recombination proteins | Studying Rad51/Polθ dynamics |
| CRISPR knockout screen | Genes affecting recombination | Genome-wide regulator discovery |
| In vitro strand invasion assay | Rad51-mediated D-loop formation | Mechanistic studies |
| Holliday junction resolution assay | Nuclease/helicase activity | Resolution mechanism |
| Cell cycle synchronization | Phase-specific recombination | Cell cycle regulation |
| Phospho-proteomics | Phosphorylation of repair proteins | Kinase signaling |
| Bioinformatics pathway analysis | Functional enrichment of screen hits | Data interpretation |
Recombination reporter assays
Direct repeat and inverted repeat reporters are used to measure the frequency of mitotic recombination. These assays typically employ two mutated copies of a reporter gene (e.g., GFP or lacZ) that can recombine to restore function, allowing quantification of recombination events by fluorescence or colony formation. Cell cycle synchronization and flow cytometry can link recombination frequency to specific phases.
Live-cell imaging of recombination proteins
Fluorescently tagged Rad51, Rad54, and Polθ can be visualized in living cells to track their recruitment to DNA damage sites. Time-lapse microscopy reveals the kinetics of filament formation and resolution, and can be combined with cell cycle reporters to study regulation.
CRISPR screening and bioinformatics
Genome-wide CRISPR knockout or activation screens can identify regulators of mitotic recombination. Cells with a recombination reporter are subjected to library screening, and next-generation sequencing identifies enriched or depleted sgRNAs. Bioinformatics pipelines then map hits to pathways and predict functional networks.
Biochemical reconstitution
Purified proteins can be used to reconstitute key steps of recombination in vitro, such as Rad51 filament formation, strand invasion, and Holliday junction resolution. These assays allow precise dissection of regulatory mechanisms, including the effects of phosphorylation or inhibitory proteins like Hed1.
How CRISPR Can Be Used to Study GO:0000019 regulation of mitotic recombination
Knockout
CRISPR knockout is used to delete genes such as RAD51, POLQ, or PLK1 to assess their requirement for mitotic recombination. Knockout cell lines can be subjected to recombination reporter assays to quantify changes in frequency and to test sensitivity to DNA-damaging agents.
Point Mutation
Point mutations can be introduced to mimic phosphorylation or inactivate catalytic residues. For example, mutating the PLK1 phosphorylation sites on Polθ can reveal their importance for mitotic DSB repair. Similarly, point mutations in RAD51 can dissect its filament stability.
Knock-in
Knock-in of tagged versions of recombination proteins (e.g., GFP-Rad51) allows live-cell imaging and proteomic analysis. Knock-in of patient-derived mutations can model disease-associated variants and their impact on recombination regulation.
Overexpression
Overexpression of genes like POLQ or RAD51 can test whether increased levels drive therapy resistance or genome instability. Inducible systems provide controlled expression to study dosage effects.
How EDITGENE Supports regulation of mitotic recombination Research
Researchers studying regulation of mitotic recombination-related genes often need to determine whether a candidate gene is causally involved in the process or is merely correlated. EDITGENE provides a comprehensive suite of CRISPR services to enable precise genetic manipulation and functional interrogation of recombination regulators.
Contact EDITGENE today to design your custom CRISPR model for regulation of mitotic recombination research.
Frequently Asked Questions About regulation of mitotic recombination
What is GO:0000019 regulation of mitotic recombination?
GO:0000019 is a Gene Ontology term defined as any process that modulates the frequency, rate or extent of DNA recombination during mitosis.
What genes are involved in regulation of mitotic recombination?
Key genes include RAD51, RAD54, HED1, POLQ, PLK1, and MRE11, among others.
How is mitotic recombination regulated during the cell cycle?
It is regulated by cyclin-dependent kinases that restrict recombination to S and G2 phases, and by mitotic kinases like PLK1 that promote backup repair.
What is the role of Polθ in mitotic recombination?
Polθ mediates microhomology-mediated end joining (MMEJ) during mitosis and is phosphorylated by PLK1 to promote DSB repair.
Why is regulation of mitotic recombination important for cancer?
Dysregulation leads to genome instability, aneuploidy, and therapy resistance, making it a target for cancer treatment.
What experimental models are used to study mitotic recombination?
Common models include yeast, human cell lines with recombination reporters, and CRISPR knockout/knock-in cells.
How can CRISPR be used to study regulation of mitotic recombination?
CRISPR enables knockout, point mutation, knock-in, and overexpression of recombination genes to test their function.
What methods measure mitotic recombination frequency?
Direct repeat recombination assays, live-cell imaging, and CRISPR screens are commonly used.
What is the difference between mitotic and meiotic recombination regulation?
Mitotic recombination is restricted to S/G2 and inhibited by factors like Hed1, while meiotic recombination involves programmed DSBs and different regulators.
How does EDITGENE support research on regulation of mitotic recombination?
EDITGENE offers CRISPR knockout, point mutation, knock-in, overexpression, library screening, and bioinformatics services to dissect recombination mechanisms.
Conclusion
Regulation of mitotic recombination (GO:0000019) is a critical biological process that ensures genome stability during cell division. Its dysregulation is linked to cancer, therapy resistance, and genomic disorders. Understanding the molecular players and their regulation provides opportunities for therapeutic intervention. EDITGENE's comprehensive CRISPR services empower researchers to uncover causal mechanisms and develop new models for studying this process.
References
- 1. Symington LS et al.. 2014. Mechanisms and regulation of mitotic recombination in Saccharomyces cerevisiae.. Genetics 198(3):795-835 PMID: 25381364
- 2. Shin Y et al.. 2025. Structural basis for Rad54- and Hed1-mediated regulation of Rad51 during the transition from mitotic to meiotic recombination.. Proc Natl Acad Sci U S A 122(37):e2510007122 PMID: 40932772
- 3. Zafar F et al.. 2017. Regulation of mitotic recombination between DNA repeats in centromeres.. Nucleic Acids Res 45(19):11222-11235 PMID: 28977643
- 4. Gelot C et al.. 2023. Polθ is phosphorylated by PLK1 to repair double-strand breaks in mitosis.. Nature 621(7978):415-422 PMID: 37674080
- 5. Wild P et al.. 2019. Network Rewiring of Homologous Recombination Enzymes during Mitotic Proliferation and Meiosis.. Mol Cell 75(4):859-874.e4 PMID: 31351878
- 6. West SC et al.. 2015. Resolution of Recombination Intermediates: Mechanisms and Regulation.. Cold Spring Harb Symp Quant Biol 80:103-9 PMID: 26370409
- 7. Mathiasen DP et al.. 2014. Cell cycle regulation of homologous recombination in Saccharomyces cerevisiae.. FEMS Microbiol Rev 38(2):172-84 PMID: 24483249
- 8. Talhaoui I et al.. 2016. The nucleolytic resolution of recombination intermediates in yeast mitotic cells.. FEMS Yeast Res 16(6) PMID: 27509904
